EQ - Equillium Inc
Previous close
1.08
0 0%
Share volume: 119,885
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.08
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-14 | 2023-03-23 | 2023-05-11 | 2023-08-09 | 2023-11-08 | 2024-03-25 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 62.472 M | 48.631 M | 78.421 M | 71.790 M | 58.764 M | 55.225 M | 50.530 M | 43.597 M | |
| Current Assets | 60.482 M | 46.776 M | 76.735 M | 70.220 M | 57.356 M | 53.911 M | 49.349 M | 42.480 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 2.920 M | 2.254 M | 2.874 M | 4.804 M | 5.235 M | 3.836 M | 4.748 M | 5.147 M | |
| Short Term Investments | 2.920 M | 2.254 M | 2.874 M | 4.804 M | 5.235 M | 3.836 M | 4.748 M | 5.147 M | |
| Total Receivables | 0.000 | 0.000 | 2.838 M | 3.424 M | 3.743 M | 3.769 M | 3.735 M | 5.048 M | |
| Current Cash | 57.562 M | 44.522 M | 71.023 M | 61.992 M | 48.378 M | 46.306 M | 40.866 M | 32.285 M | |
| Total Non-current Assets | 1.990 M | 1.855 M | 1.686 M | 1.570 M | 1.408 M | 1.314 M | 1.181 M | 1.117 M | |
| Property Plant Equipment | 451.000 K | 423.000 K | 391.000 K | 360.000 K | 329.000 K | 313.000 K | 315.000 K | 361.000 K | |
| Other Assets | 1.539 M | 1.432 M | 1.295 M | 1.210 M | 1.079 M | 1.001 M | 866.000 K | 756.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 62.472 M | 48.631 M | 78.421 M | 71.790 M | 58.764 M | 55.225 M | 50.530 M | 43.597 M | |
| Total liabilities | 22.205 M | 20.471 M | 46.479 M | 42.521 M | 31.783 M | 31.117 M | 27.957 M | 22.503 M | |
| Total current liabilities | 15.188 M | 14.930 M | 32.038 M | 32.020 M | 25.218 M | 28.199 M | 27.573 M | 22.208 M | |
| Accounts Payable | 5.091 M | 2.469 M | 3.977 M | 5.692 M | 3.026 M | 3.635 M | 4.707 M | 2.778 M | |
| Other liabilities | 0.000 | 0.000 | 10.378 M | 7.941 M | 5.956 M | 2.420 M | 0.000 | 0.000 | |
| Current long term debt | 4.720 M | 6.135 M | 6.122 M | 6.118 M | 416.000 K | 428.000 K | 440.000 K | 424.000 K | |
| Long term debt | 7.017 M | 5.541 M | 4.063 M | 2.560 M | 609.000 K | 498.000 K | 384.000 K | 295.000 K | |
| Other liabilities | 0.000 | 0.000 | 10.378 M | 7.941 M | 5.956 M | 2.420 M | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 40.267 M | 28.160 M | 31.942 M | 29.269 M | 26.981 M | 24.108 M | 22.573 M | 21.094 M | |
| Common stock | 34.293 M | 34.352 M | 34.401 M | 34.414 M | 34.450 M | 34.879 M | 35.163 M | 35.255 M | |
| Retained earnings | -161.523 M | -175.178 M | -172.405 M | -176.345 M | -179.688 M | -183.398 M | -185.740 M | -188.474 M |